A promising new strategy for antimalarial treatment? A recent study discovers a gene regulation inhibitor that selectively ...

The parasite that causes malaria requires precise control of gene expression to progress through the various stages of its ...

Researchers identified an enzyme that helps Plasmodium-infected red blood cells adhere to the placenta, providing molecular ...

Oberstaller and her colleagues published their paper, “Supersaturation mutagenesis reveals adaptive rewiring of essential ...

Epigenetic inhibitors as a promising new antimalarial intervention strategy? A new study identifies an inhibitor of gene ...

A multinational team has identified PfSnf2L, a key epigenetic regulator in Plasmodium falciparum, the deadliest malaria ...

A new, comprehensive map of all the genes essential for blood infections in Plasmodium knowlesi (P. knowlesi), a parasite that causes malaria in humans, has been generated. The map contains the most ...

A study on FUO in Guinea found diverse bacterial and viral infections, frequent misdiagnoses, and high antibiotic resistance, ...

Each year, around 249 million human cases of malaria are caused by a Plasmodium species, resulting in about 608,000 deaths. P. knowlesi is one of several species responsible for human malaria.

The journey to eliminate malaria is complex, hindered by the parasite's adaptability and challenges in vaccine development.

Resistance to antimalarial drugs is a growing concern with research indicating that resistance to first-line treatments has ...

Uganda’s malaria burden is staggering, with some areas such as Apac District recording the world’s highest density of ...